StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by Liked2Thinkon Jun 21, 2021 12:16pm

138 Views

Post# 33420567

Low Volume Everyone in Holding Pattern

This AGM and Q2 reports are shaping up to be the make or break time for Stagezero.

We got hosed with the pathetic Aristotle "rollout" and the SP proves that.

1. If everything the board is pushing doesnt get passed - SP tankage
2. If they dont give us some actual numbers on aristotle - SP tankage

If the bumbled didnt wake up "management" then nothing will.

Remember when the last RS happened and so many said it will just go back to its original SP eventually? Technically it has gone lower than that but what they meant was back to 8 cents. Well if Tripp $crews the pooch this time then for sure that will be the case.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland